E.A. Kulyaev (1), A.V. Grafov (1), O. V. Falameeva (1), V.S. Kholodkin (1), M.A Sadovoy (1, 2), O.V. Tsygankova (2)
EXPERIENCE OF THE USE OF ZOLEDRONIC ACID (REZOLLASTIN 5 MG/6.25 ML, OOO «NATIVA») IN PATIENTS WITH LOW BONE MINERAL DENSITY IN THE SETTINGS OF THE CENTER FOR PREVENTION OF OSTEOPOROSIS OF NOVOSIBIRSK SRITO
|
№19 / 2017
|
N.Yu. Karpova, M.A. Rashid, I.V. Pogonchenkova
OSTEOPOROSIS AFTER STROKE: FEATURES OF DEVELOPMENT, DIAGNOSIS AND TREATMENT
|
№19 / 2015
|
I.E. Zhila, O.V. Galkina, E.O. Bogdanova, N.L. Shaporova, O.V. Dudina
OSTEOPOROSIS IN PATIENTS WITH BRONCHO-OBSTRUCTIVE PATHOLOGY
|
№s4-15 / 2015
|
A.A. Maryanovsky
ANALYTICAL REVIEW OF CLINICAL STUDIES ON THE EFFECTIVENESS OF COMPLEX HOMEOPATHIC PREPARATION TRAUMEEL S
|
№16 / 2015
|
S.G. Anikin, T.A. Korotkova
THE USE OF ALENDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS
|
№7 / 2015
|
D.V. Akimova
RISK FACTORS FOR OSTEOPOROSIS
|
№7 / 2014
|
E.V. Biryukova
DO WE KNOW EVERYTHING ABOUT TREATMENT OF STEROID-INDUCED OSTEOPOROSIS?
|
№s5-13 / 2013
|
Rozhinskaya L.Ya.
Osteoporosis: Topical Issues
|
№s1-12 / 2012
|
Ye.G.Zotkin, I.I. Zubkova, O. G.Khurtsilava
Individualized Approach To Pharmacological Prevention And Treatment Of Osteoporosis
|
№6 / 2012
|
E. Shakht, L. Dukas, F. Richchi
Combined Therapies Of Osteoporosis: Bisphosphonates And The D-hormone Analogs
|
№16 / 2011
|
L.Rozhinskaya, Z.Belaya С. 3945
Osteoporosis In The Practice Of The Physician-endocrinologist: Modern Methods Of Treatment
|
№3 / 2010
|